Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07124351 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)

Name: Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) — clinical trial record (NCT07124351)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorCedars-Sinai Medical Center

Started2025-09-05

View on ClinicalTrials.gov ↗

Record status

This record was last updated September 15, 2025 (before its estimated August 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2025-09-09

Not Yet Recruiting→Recruiting Study Status, Study Design, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

PhasePhase 1→Phase 4

Start dateestimated 2025-08→confirmed 2025-09-05

Study sitesdetails revised at 1 of 1 site

2025-08-08

Original filing

Cedars-Sinai Medical Center

133 trials monitored

See 15 trials at risk

Gastric Cancer

1,194 trials monitored

See 60 trials at risk

Esophageal Cancer

1,010 trials monitored

See 51 trials at risk

This is an open-label study in adults to determine feasibility of using CYTALUX™ (pafolacianine) injection with near-infrared (NIR) fluorescent imaging for detecting any type adenocarcinoma (gastric, esophageal and appendiceal).

Trial Details

NCT Number	NCT07124351
Lead Sponsor	Cedars-Sinai Medical Center Collaborators: On Target Laboratories, LLC
Conditions	Gastrointestinal Cancer, Gastric Cancer, Esophageal Cancer, Appendiceal Cancer
Enrollment	15 participants
Start Date	2025-09-05
Primary Completion	2026-08 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2025-09-15